Literature DB >> 17590158

Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation.

Yanik Roussy1, Marie-Pierre Bertrand Duchesne, Guy Gagnon.   

Abstract

OBJECTIVES: Aims of this controlled study were to determine the effects of activated human platelet-rich plasmas (PRPs) on early and mature bone formation in vivo, and to characterize the effect of PRP activation on growth factors release and endothelial cell division in vitro.
MATERIAL AND METHODS: PRPs were prepared from four volunteers with the platelet concentrate collector system (PCCS) system and activated with three concentrations of calcium and thrombin. Platelet-derived growth factor (PDGF)-BB, vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-beta) and interleukin-1beta (IL-1beta) levels released in supernatants were measured by ELISA, at time 0, 1h, 24h and 6 days following PRP activation. Mitogenic potential of PRP supernatants were tested on endothelial cells in vitro, and the effects of activated human PRPs on bone formation in vivo were measured in athymic rats by micro-CT analyses.
RESULTS: Activation of PRPs with calcium and thrombin triggered an immediate release of VEGF, PDGF-BB and TGF-beta and a delayed release of IL-1beta in PRP supernatants. Higher endothelial cell division was observed with supernatants from activated PRPs than from non-activated PRPs. Positive correlations were observed between VEGF levels and endothelial cell division and bone formation. A negative correlation was also found between PDGF-BB concentration and bone formation. However, early and mature bone formations with activated PRPs did not significantly differ from the ones obtained in the control group.
CONCLUSIONS: Activation of PRPs with calcium and thrombin regulates growth factors release and endothelial cell division in vitro. However, activated PRPs does not improve the early or mature bone formations in vivo in this athymic rat model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590158     DOI: 10.1111/j.1600-0501.2007.01385.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  23 in total

1.  Effect of activated autologous platelet-rich plasma on proliferation and osteogenic differentiation of human adipose-derived stem cells in vitro.

Authors:  Fang-Tian Xu; Hong-Mian Li; Qing-Shui Yin; Zhi-Jie Liang; Min-Hong Huang; Guang-Yi Chi; Lu Huang; Da-Lie Liu; Hua Nan
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

2.  Clinical evaluation of use of platelet rich plasma in bone healing.

Authors:  Kailas T Gawai; C R Sobhana
Journal:  J Maxillofac Oral Surg       Date:  2014-01-09

3.  Autologous platelet-rich plasma: a biological supplement to enhance adipose-derived mesenchymal stem cell expansion.

Authors:  Fatemeh Atashi; Marisa E E Jaconi; Brigitte Pittet-Cuénod; Ali Modarressi
Journal:  Tissue Eng Part C Methods       Date:  2014-08-19       Impact factor: 3.056

4.  Platelet-rich plasma activation in combination with biphasic osteochondral scaffolds-conditions for maximal growth factor production.

Authors:  Alan Getgood; Frances Henson; Roger Brooks; Lisa A Fortier; Neil Rushton
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-02-23       Impact factor: 4.342

Review 5.  Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?

Authors:  Montserrat Serra-Millàs
Journal:  World J Psychiatry       Date:  2016-03-22

6.  Antidepressants and anti-inflammatory drugs differentially reduce the release of NGF and BDNF from rat platelets.

Authors:  T Hochstrasser; D Ehrlich; B Sperner-Unterweger; C Humpel
Journal:  Pharmacopsychiatry       Date:  2012-06-14       Impact factor: 5.788

7.  Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material.

Authors:  Eun-Seok Kim; Jae-Jin Kim; Eun-Jin Park
Journal:  J Adv Prosthodont       Date:  2010-03-31       Impact factor: 1.904

8.  Use of imatinib in the prevention of heterotopic ossification.

Authors:  Clément M L Werner; Stefan M Zimmermann; Carola C Würgler-Hauri; Joseph M Lane; Guido A Wanner; Hans-Peter Simmen
Journal:  HSS J       Date:  2013-06-21

9.  Effects of a mixture of growth factors and proteins on the development of the osteogenic phenotype in human alveolar bone cell cultures.

Authors:  Paulo Tambasco de Oliveira; Marcos Andrade de Oliva; William Marcatti Amarú Maximiano; Karen Elaine Vasconcelos Sebastião; Grasiele Edilaine Crippa; Pietro Ciancaglini; Márcio Mateus Beloti; Antonio Nanci; Adalberto Luiz Rosa
Journal:  J Histochem Cytochem       Date:  2008-03-31       Impact factor: 2.479

10.  Treatment with a growth factor-protein mixture inhibits formation of mineralized nodules in osteogenic cell cultures grown on titanium.

Authors:  Marcos Andrade de Oliva; William Marcatti Amarú Maximiano; Larissa Moreira Spínola de Castro; Paulo Eliandro da Silva; Roger Rodrigo Fernandes; Pietro Ciancaglini; Márcio Mateus Beloti; Antonio Nanci; Adalberto Luiz Rosa; Paulo Tambasco de Oliveira
Journal:  J Histochem Cytochem       Date:  2008-11-24       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.